Creative Biolabs is pleased to present a cutting-edge webinar focused on microfluidic tumor modeling, a rapidly advancing technology that bridges the gap between conventional in vitro systems and in vivo environments.

Led by acclaimed scientist Dr. Mohsen Akbari, this session will explore the development and application of tumoroid-on-a-chip systems, offering attendees a comprehensive look into microfluidic platforms designed for high-resolution, physiologically relevant immunotherapy screening.

This event reflects Creative Biolabs’ commitment to advancing microfluidic innovations that drive precision and translational impact in cancer research.

What You’ll Learn

Traditional 2D cultures and animal models often fall short in predicting human tumor responses to therapies. To address this, Dr. Akbari and his team have developed a microfluidic tumoroid platform that replicates the 3D architecture and functional complexity of the tumor microenvironment.

This webinar will cover:

  • The engineering journey: from compartmentalized chips to plate-based scalability
  • Techniques for incorporating ECM and tumor-stroma interactions
  • Real-world examples of mono- and combination immunotherapy screening
  • Advantages of tumor-on-chip systems over standard drug testing models